Background. An association between use of oral fluoroquinolones (FQs) and retinal detachment remains controversial. This study was to determine the association of recent use of oral FQs and rhegmatogenous retinal detachment (RRD) after adjustment for confounding factors known to be associated with RRD.
Fluoroquinolones (FQs) are among the most commonly prescribed oral antimicrobial agents for most infectious diseases worldwide [1, 2] . They are particularly attractive because of their ease of administration, broad spectrum, favorable absorption, tissue distribution, bactericidal properties, and minimal side effects [1] . Uncommon adverse effects include seizure, tendon rupture, torsades de pointes, hepatotoxicity, and dysglycemias [2] . An association between the use of oral FQs and retinal detachment has been recently described in several anecdotal reports and a populationbased study [3] . The authors speculated that because FQs are well distributed in the vitreous cavity [4, 5] , they may have a deleterious effect on the collagen or connective tissues. One of the major criticisms of the population-based study was lack of differentiation of the various types of retinal detachment [6] . The 3 types of retinal detachment are exudative, tractional, and rhegmatogenous. Each has a distinct pathogenesis and associated risk factors [6] . The presumed mechanism of FQs on connective tissues is similar to that of rhegmatogenous retinal detachment (RRD). RRD could not be distinguished from other types of retinal detachment in the population-based study because of the limited coding system in British Columbia [3] . In addition, several confounding factors such as ocular trauma [7] were not considered in the analysis. Other criticisms include the inconsistent association between current (1-7 days) and recent days) use of FQ with retinal detachment. This may be attributed to small cases numbers over a wide range of incubation periods (8-365 days) [4, [6] [7] [8] [9] . Accordingly more detailed studies were needed to confirm the initial observations.
To weigh potential risk-benefit ratios, it is necessary to identify the specific potentially toxic agent and the population at highest risk for toxicity. Various FQs and predisposing host factors have been proposed to be important risk factors for the adverse effects of FQs. For example, FQ-associated seizure is associated with ciprofloxacin, enoxacin, and norfloxacin in patients with underlying central nervous system disorders [2] . Torsades de pointes is associated with sparfloxacin in patients with a reduced repolarization reserve [2] .
We used the 1998-2010 Taiwan National Health Insurance Research Database to develop a current population-based, cohort study. Two parallel groups were used to compare the incidence of RRD by propensity score matching of adults who had been treated with an oral FQ or amoxicillin. We took into consideration several well-known confounding factors including underlying ophthalmic conditions and used RRD as the well-defined endpoint. Types of FQs or underlying ophthalmic conditions known to be associated for RRD were analyzed to determine whether certain populations were at greater risk and whether different types of FQs carried the same risk for RRD.
METHODS

Data Source
The Taiwan National Health Insurance (NHI), established in 1995, includes 98% of the population because of mandatory, universal enrollment. The NHI Research Database (NHIRD) of the National Health Research Institute collects and stores all demographic data and diagnoses according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as well as all procedures and medications [10] . The Longitudinal Health Insurance Database dataset contains complete data of 1 000 000 randomly sampled beneficiaries from the original NHIRD. The dataset used in this study consists of de-identified secondary data released to the public for research purposes. This study was exempt from full review by the institutional review board.
Study Design
Setting
This was a population-based, observational, retrospective cohort study conducted in Taiwan. To determine the association between oral FQs and RRD, we compared the incidence of RRD in 2 propensity score-matched cohorts. The cohorts consisted of adults who received prescriptions for oral FQs or oral amoxicillin (Figure 1 ). We extracted clinical information from the Longitudinal Health Insurance Database dataset for all adults from January 1998 to December 2010. Data for each individual were further extracted from the Longitudinal Health Insurance Database dataset from January 1995 to December 1997 to ensure that all individuals were available for at least a 3-year follow-up before enrollment and to ensure confirmation of comorbidities [10] and matching.
Participants
The FQ cohort consisted of adults (aged >18 years) who were prescribed >3 consecutive doses of an oral FQ at the time they entered the study. The amoxicillin cohort was similarly defined. The same patient could be assigned to both cohorts at different time points. The following groups were excluded from the study (Figure 1 and Supplementary Table 1): patients treated with FQs or amoxicillin during the prior 90 days; hospitalized 90 days prior to enrollment; had a previous diagnosis of retinal detachment or procedure for repair of retinal detachment, including a scleral buckle, a vitrectomy, a pneumatic retinopexy, retinal cryopexy or laser therapy; or were blind or received procedures for enucleation or evisceration of eyes.
Matching
To adjust for confounding factors associated with use of antimicrobial agents for respiratory and other infections, we selected oral amoxicillin as the comparator drug. Oral amoxicillin has not been associated with RRD. We identified 1 amoxicillin control for each qualifying oral FQ prescription, according to the year of the prescription, age, sex, diabetes mellitus [3] , and ophthalmic conditions known to increase the risk of RRD, and a propensity score (±0.1) [11] . To avoid the confounding effect of cough on precipitating RRD, we also matched prescriptions for respiratory tract infections [8] .
Definition of Variables
Underlying ophthalmic conditions associated with RRD consisted of endophthalmitis, retinitis, especially cytomegalovirus (CMV) retinitis, eye trauma, retinal vascular occlusion, vitreous hemorrhage, high myopia, proliferative diabetic retinopathy, and cataract surgery [12] [13] [14] [15] [16] [17] . The diagnosis of endophthalmitis was confirmed by ICD-9-CM codes or procedures related to endophthalmitis, including intravitreal antibiotic injection or a vitreous biopsy [3] . Because there is no ICD-9-CM code specific for CMV retinitis, CMV diseases or AIDS, which commonly predisposes individuals to CMV retinitis, were deemed as underlying ophthalmic conditions. The diagnosis of other diseases was made by ICD-9-CM codes. Cataract operations were confirmed by the procedure code (Supplementary Table 1 ).
The ICD-9-CM codes of respiratory tract infections included acute respiratory infections (ICD-9-CM codes 461.X-466.X and 034.0), bacterial pneumonia (ICD-9-CM codes 481.X, 482.X, 485.X, and 486.X), and chronic obstructive pulmonary diseases with acute exacerbation (ICD-9-CM code 491.21). Other comorbidities were defined based on the previous study [10] .
Outcomes
Both cohorts were followed for 90 days until diagnosed with RRD, prescribed with the other antimicrobial (ie, the FQ cohort with an oral amoxicillin or the amoxicillin cohort with an oral FQ), lost to follow-up, or had died within the period of observation. The endpoint of this study was the occurrence of RRD confirmed by ICD-9-CM codes 361.00-361.05, as recorded by ophthalmologists.
Statistical Analysis
Pearson χ 2 tests were used for categorical variables, whereas independent t tests and Mann-Whitney U tests were used for parametric and nonparametric continuous variables, respectively. The propensity score for the likelihood of using FQ was calculated by multivariate logistic regression analysis, conditional on the baseline covariates listed in Table 1 . The cumulative incidence of RRD was calculated by the Kaplan-Meier method and was compared by log-rank test. Cox proportional hazards models were used to compute the hazard ratios (HRs) accompanying 95% confidence intervals (CIs). We also tested if the association between using FQ and RRD were significantly interacted by age, sex, diabetes, respiratory tract infection, and underlying ophthalmic conditions by likelihood ratio testing of nested models and performed stratified subgroup analyses. A P value of <.05 was considered significant. Microsoft SQL Server 2008 R2 (Microsoft Corp, Redmond, Washington) was used for data linkage, processing, and sampling. All analyses were conducted using Stata statistical software version 12.0 (StataCorp).
RESULTS
Characteristics of the Study Cohorts
This study cohort included 178 179 prescriptions for an oral FQ and 178 179 matched prescriptions for amoxicillin. The median number of days of therapy was 3 days in both cohorts. The subjects were predominantly female (59.2%) with a mean age of 47 years (SD, 18 years). Up to 40.8% of the prescriptions were for respiratory tract infections in both the FQ and amoxicillin cohorts. The propensity scores for the likelihood of using an FQ or amoxicillin were similar in both cohorts, but the FQ cohort was more likely to have comorbidities including chronic renal disease, coronary artery disease, peripheral vascular disease, dyslipidemia, and autoimmune disease. The detailed findings are shown in Table 1 .
Risk of Rhegmatogenous Retinal Detachment
During the 90-day follow-up period, 96 patients (0.054%) in the FQ cohort developed RRD compared to 46 (0.026%) among the amoxicillin cohort. The median interval between use of an FQ and onset of RRD was 35.5 days (interquartile range [IQR], 14-57 days) and 48.5 days (IQR, 25-67 days) for amoxicillin. The crude HR for RRD with use of an FQ was 2.09 (95% CI, 1.47-2.99; P < .001); the adjusted HR was 2.07 (95% CI, 1.45-2.96; P < .001). In contrast, the crude and adjusted HRs for exudative and tractional retinal detachment were 1.02 (95% CI, .69-1.49; P = .937) and 1.00 (95% CI, .68-1.48; P = . 980). The cumulative incidence of RRD (Figure 2 ) in the FQ and amoxicillin cohort was significantly different (log-rank test, P < .001).
Ofloxacin was the most commonly prescribed FQ during the study period, followed by norfloxacin, ciprofloxacin, and levofloxacin ( Table 2 Table 2 ). After adjusting for comorbidities (Supplementary Table 3) , those who received ciprofloxacin or norfloxacin still had a higher risk for RRD during the following 90 days (adjusted HR, 1.84; 95% CI, 1.18-2.88; P = .007). Abbreviations: COPD, chronic obstructive pulmonary disease; NT, New Taiwan Dollar; SD, standard deviation. a At the time that the prescriptions for fluoroquinolones were filled and at the beginning of the control period for persons who received amoxicillin. Tests of interaction were performed for age, sex, diabetes, respiratory tract infection, and underlying ophthalmic conditions. None of these were statistically significant. The risk of FQ on RRD was consistent in all subgroups. The detailed findings are shown in Table 3 .
DISCUSSION
Retinal detachment was not considered an adverse effect of oral FQs until the recent publication of a population-based study by Etminan et al [3] . The current population-based, cohort study of adults treated with an oral FQ or amoxicillin provides further evidence of an association between use of oral FQs and RRD after matching for confounding factors. Age, sex, diabetes mellitus, indications for antimicrobial prescription, or the known RRD underlying ophthalmic conditions did not increase the risk of FQ-related RRD. The risk of development of RRD varied according to individual FQs prescribed. The strongest associations were with ciprofloxacin and norfloxacin. There was no significant effect for levofloxacin and ofloxacin.
The strengths of the current study include its large size, parallel-cohort design, use of an amoxicillin-treated cohort to decrease confounding by respiratory and other common infectious diseases, exclusion of prior or concomitant use of FQs and amoxicillin, adjustment for confounding factors, and a well-defined endpoint. A prospective, randomized controlled trial would have been prohibitively expensive because of the very large number of patients that would need to be enrolled to detect the small number of cases of RRD. The limitations of this study include insufficient numbers to detect the effect of FQs on RRD in patients with each specific underlying ophthalmic condition. The 90-day follow-up period might have been too short to detect late-onset RRD. We had therefore extended the follow-up period from 90 days to 365 days. A total of 228 patients (0.13%) in the FQ cohort developed RRD during 365-day follow-up compared to 164 (0.09%) in the amoxicillin cohort. The adjusted HR was 1.40 (95% CI, 1.14-1.71; P < .001).
The cumulative incidence of RRD in the FQ cohort was still higher than in the amoxicillin cohort (log-rank test, P < .001). However, the interpretation of these results may be hampered by confounding factors during the long follow-up period. The exact mechanisms by which FQs increase the risk for RRD remain unclear. Etminan et al [3] proposed that the effect is similar to FQ-associated tendinopathy [18] . Some of the mechanisms that have been considered are an ischemic vascular process or direct toxicity to collagen [2, 19] . Because the retina is attached to the vitreous body by collagen fibers, it has been proposed that the presence of FQs [20] in the vitreous body may interfere with collagen synthesis, resulting in retinal detachment [3] . However, this assumption must account for the association with current use of FQs (1-7 days) but not recent use (8-365 days after FQ prescription). These differences may be due to the small sample size in the recent use group [3] . In our study, the increasing cumulative incidence after FQ prescription compared to amoxicillin supports this assumption.
We also demonstrated that the risk of RRD differed according to various FQs. Similar differences among FQs have been noted for other FQ-associated side effects [2, 21] . Whether the level of FQs concentration in the vitreous body or the chemical structures of FQs was associated with RRD was unknown. Depending on the dosing regimen, the drug concentration in vitreous body has been shown to range from .19 to 1.21 µg/mL for ciprofloxacin [22] , .32 to 2.39 µg/mL for levofloxacin [23] [24] [25] , and 1.53-2.01 µg/mL for ofloxacin [26] . These results are difficult to compare and must be interpreted with caution because of the different sampling times, dosing regimens, and the inability to monitor the drug levels continuously. Differences in the chemical structure of quinolones also needs to be considered. FQs with 7-piperazine were more commonly associated with epilepsy [27] , whereas 8-position substituent with halogen may result in photosensitivity [21] . It is intriguing that the risk of RRD was similar among the general population and those with underlying ophthalmic conditions. Therefore, the same precautions need to be considered in all groups.
In conclusion, the current study provides additional support for the association between oral FQs and RRD. Ciprofloxacin carried the highest risk, followed by norfloxacin after adjusting for comorbidities. The risk of RRD did not increase in relation to age, sex, diabetes, indications for antimicrobials, or underlying ophthalmic conditions.
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